GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Titan Medical Inc (FRA:QTNA) » Definitions » Debt-to-EBITDA

Titan Medical (FRA:QTNA) Debt-to-EBITDA : -0.39 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Titan Medical Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Titan Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.45 Mil. Titan Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.67 Mil. Titan Medical's annualized EBITDA for the quarter that ended in Mar. 2024 was €-2.84 Mil. Titan Medical's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was -0.39.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Titan Medical's Debt-to-EBITDA or its related term are showing as below:

FRA:QTNA' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.12   Med: -0.04   Max: 0.18
Current: 0.14

During the past 13 years, the highest Debt-to-EBITDA Ratio of Titan Medical was 0.18. The lowest was -0.12. And the median was -0.04.

FRA:QTNA's Debt-to-EBITDA is ranked better than
83.98% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 1.25 vs FRA:QTNA: 0.14

Titan Medical Debt-to-EBITDA Historical Data

The historical data trend for Titan Medical's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Medical Debt-to-EBITDA Chart

Titan Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.12 -0.10 -0.04 0.18

Titan Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 0.03 2.71 -0.11 -0.39

Competitive Comparison of Titan Medical's Debt-to-EBITDA

For the Medical Devices subindustry, Titan Medical's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Titan Medical's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Titan Medical's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Titan Medical's Debt-to-EBITDA falls into.



Titan Medical Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Titan Medical's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.428 + 0.785) / 6.771
=0.18

Titan Medical's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.445 + 0.67) / -2.84
=-0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Titan Medical  (FRA:QTNA) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Titan Medical Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Titan Medical's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Titan Medical (FRA:QTNA) Business Description

Traded in Other Exchanges
Address
76 Berkeley Street, Toronto, ON, CAN, M5A 2W7
Titan Medical Inc is in the research and development stage and is focused on the continued design and development of robotic-assisted surgical technologies for application in minimally invasive surgery including the development of the Enos robotic single-access surgical system.

Titan Medical (FRA:QTNA) Headlines